Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23827249 | 0.94 | TYMP (0.40) | TYMPKDM4ETAS1R3TAS1R1HPGD | |
| SCHEMBL23827271 | 0.88 | TYMP (0.43) | TYMPKDM4ETAS1R3TAS1R1HPGD | |
| SCHEMBL24176894 | 0.84 | TYMP (0.42) | TYMPKDM4ETAS1R3TAS1R1HPGD | |
| SCHEMBL23827328 | 0.82 | TYMP (0.42) | TYMPKDM4ETAS1R3TAS1R1HPGD | |
| SCHEMBL23827212 | 0.82 | KDM4E (0.35) | TYMPKDM4E | |
| SCHEMBL23827313 | 0.79 | CDK5 (0.35) | TYMP | |
| SCHEMBL19362152 | 0.79 | TYMP (0.45) | TYMPKDM4ETAS1R3TAS1R1HPGD | |
| SCHEMBL1096942 | 0.79 | TYMP (0.45) | TYMPKDM4ETAS1R3TAS1R1HPGD | |
| SCHEMBL24513002 | 0.79 | TYMP (0.45) | TYMPKDM4ETAS1R3TAS1R1HPGD | |
| SCHEMBL24177252 | 0.78 | TYMP (0.41) | TYMPKDM4ETAS1R3TAS1R1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220002336-A1 | CROSSLINKED ARTIFICIAL NUCLEIC ACID ALNA | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2022-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220002336-A1 | CROSSLINKED ARTIFICIAL NUCLEIC ACID ALNA | POLN, DDX21, MUS81 | TYMP 1322/4885KDM4E 3126/4885TAS1R3 3625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.